Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Lupus Nephritis
NCT06113900Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dapagliflozin in lupus nephritis (LN) (2 arms), sponsored by Ain Shams University. Primary endpoint: Renal Function Tests at 6 months. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT06113900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06113900.